Evidence map›Paper›PMID 35703468›Full record

ArticleJournal of thrombosis and haemostasis : JTH2022

Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition.

Senna Staessens, Mouhamed D Moussa, Adeline Pierache, Antoine Rauch, Natacha Rousse, Eric Boulleaux, Alexandre Ung, Linda Desender, Bénédicte Pradines, André Vincentelli and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Progress of extracorporeal centrifugal pumps for mechanical circulatory supports.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Platelet Adhesion and Activation in an ECMO Thrombosis-on-a-Chip Model.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 2 countries.

Senna StaessensLaboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.ORCID 0000-0001-5530-6961
Mouhamed D MoussaUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0003-3189-8119
Adeline PieracheULR 2694-METRICS (Evaluation des technologies de santé et des pratiques médicales), University of Lille, Centre Hospitalier Universitaire Lille, Lille, France.ORCID 0000-0002-8999-8326
Antoine RauchUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0002-1182-4131
Natacha RousseUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0003-2837-4285
Eric BoulleauxUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0001-6507-3495
Alexandre UngUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0003-1946-4625
Linda DesenderLaboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.ORCID 0000-0002-3449-792X
Bénédicte PradinesUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0003-0371-1580
André VincentelliUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0003-4081-786X
Olaf MercierResearch and Innovation Laboratory, INSERM U999, Marie Lannelongue Hospital, Paris Sud Saclay University, Le Plessis Robinson, France.ORCID 0000-0002-4760-6267
Julien LabreucheULR 2694-METRICS (Evaluation des technologies de santé et des pratiques médicales), University of Lille, Centre Hospitalier Universitaire Lille, Lille, France.ORCID 0000-0002-3384-0423
Alain DuhamelULR 2694-METRICS (Evaluation des technologies de santé et des pratiques médicales), University of Lille, Centre Hospitalier Universitaire Lille, Lille, France.ORCID 0000-0003-0392-7701
Eric Van BelleUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0001-6509-443X
Flavien VincentUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0002-1007-1473
Annabelle DupontUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0002-1554-9931
Karen VanhoorelbekeLaboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.ORCID 0000-0003-2288-8277
Delphine CorseauxUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0001-8642-1508
Simon F De MeyerLaboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.ORCID 0000-0002-1807-5882
Sophie SusenUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.ORCID 0000-0001-5953-163X
Inserm · FRCentre Hospitalier Universitaire de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIntra-device thrombosis remains one of the most common complications during extracorporeal membrane oxygenation (ECMO). Despite anticoagulation, approximately 35% of patients develop thrombi in the membrane oxygenator, pump heads, or tubing. The aim of this study was to describe the molecular and cellular features of ECMO thrombi and to study the main drivers of thrombus formation at different sites in the ECMO circuits. APPROACH AND

resultsThrombi (n = 85) were collected immediately after veno-arterial-(VA)-ECMO circuit removal from 25 patients: 23 thrombi from the pump, 25 from the oxygenator, and 37 from the tubing. Quantitative histological analysis was performed for the amount of red blood cells (RBCs), platelets, fibrin, von Willebrand factor (VWF), leukocytes, and citrullinated histone H3 (H3Cit). ECMO thrombi consist of a heterogenous composition with fibrin and VWF being the major thrombus components. A clustering analysis of the four major histological parameters identified two typical thrombus types: RBC-rich and RBC-poor/fibrin-rich thrombi with no significant differences in VWF and platelet content. Thrombus composition was not associated with the thrombus location, except for higher amounts of H3Cit that were found in pump and oxygenator thrombi compared to tubing samples. We observed higher blood leukocyte count and lactate dehydrogenase levels in patients with fibrin-rich thrombi.

conclusionWe found that thrombus composition is heterogenous, independent of their location, consisting of two types: RBC-rich and a fibrin-rich types. We also found that NETs play a minor role. These findings are important to improve current anticoagulation strategies in ECMO.

Indexed as

Extracorporeal Membrane OxygenationThrombosisAnticoagulantsFibrinHumansvon Willebrand FactorAnticoagulantsFibrinvon Willebrand FactorECMOfibrinhistologyNETsthrombosisthrombus composition

Identifiers

PMID35703468
PMCPMC9349827
OpenAlexW4282963239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.